Provided by Tiger Trade Technology Pte. Ltd.

SIHUAN PHARM

1.700
+0.0603.66%
Volume:79.03M
Turnover:135.10M
Market Cap:15.55B
PE:-64.39
High:1.750
Open:1.650
Low:1.650
Close:1.640
52wk High:1.920
52wk Low:0.526
Shares:9.15B
HK Float Shares:9.15B
Volume Ratio:2.03
T/O Rate:0.86%
Dividend:0.01
Dividend Rate:0.66%
EPS(LYR):-0.026
ROE:-6.73%
ROA:-1.02%
PB:3.14
PE(LYR):-64.39
PS:6.56

Loading ...

Sealand Securities Starts Sihuan Pharmaceutical Holdings Group at Buy

MT Newswires Live
·
25 mins ago

Sihuan Pharmaceutical (00460) Announces January 2026 Monthly Return

Bulletin Express
·
Feb 02

Zhytong Hong Kong Stock Analysis | UK Prime Minister's China Visit Boosts Market Sentiment, Price Hike Concepts Strengthen Collectively

Stock News
·
Jan 27

SIHUAN PHARM (00460) Surges Over 9% Again as Institutions Favor Accelerated Dual Growth from Aesthetic and Innovation Drugs

Stock News
·
Jan 27

ZhTong Hong Kong Market Analysis | Strait of Hormuz Sparks Market Jitters, Asset Classes Continue to Draw Interest

Stock News
·
Jan 26

A Look At Sihuan Pharmaceutical (SEHK:460) Valuation After New Polylactic Acid Filler Approvals

Simply Wall St.
·
Jan 24

Hong Kong Stock Movement | SIHUAN PHARM (00460) Rises Nearly 4%, Recent Approval of New "Youthful Needle" Specifications Further Enhances Regenerative Aesthetic Product Market Layout

Stock News
·
Jan 23

Why Investors Shouldn't Be Surprised By Sihuan Pharmaceutical Holdings Group Ltd.'s (HKG:460) P/S

Simply Wall St.
·
Jan 21

Sihuan Pharmaceutical (00460) Gains NMPA Approval for Additional Specifications of Its "Youth Needle" Product

Stock News
·
Jan 16

BRIEF-Sihuan Pharma Says Six New Polylactic Acid Facial Filler Specifications Approved By China's NMPA

Reuters
·
Jan 16

Sihuan Pharma - Six New Polylactic Acid Facial Filler Specifications Approved by Nmpa

THOMSON REUTERS
·
Jan 16

Xu Yanjun Appointed General Manager of Xuanzhu Biopharmaceutical

Reuters
·
Jan 05

Xuanzhu Biopharmaceutical Executive Director Li Jia Kui Resigns

Reuters
·
Jan 02

Sihuan Pharma - Repurchases 8 Mln Co Shares at Avg Price of HK$1.2511 Each

THOMSON REUTERS
·
Dec 29, 2025

Sihuan Pharmaceutical Repurchases 8 Million Shares for HKD 10 Million, Files Disclosure with HKEX

Reuters
·
Dec 29, 2025

Reframing the Narrative: A Deep Value Re-rating Path for a Transforming Platform— Aesthetics Leader + Innovative Drug Pioneer, an Undervalued Transformation Case

格隆汇
·
Dec 19, 2025

Sihuan Pharmaceutical's Trustee Buys Back Shares Under Incentive Scheme

MT Newswires Live
·
Dec 18, 2025

SIHUAN PHARM (00460): Trustee Purchases 9 Million Shares Under Share Award Scheme

Stock News
·
Dec 18, 2025

Market Focus: Can Real Estate and Consumption Find Momentum?

Stock News
·
Dec 15, 2025

SIHUAN PHARM (00460): Innovative Drug Anjiuwei® Successfully Renewed in 2025 National Reimbursement Drug List

Stock News
·
Dec 08, 2025